The phenotype of four cases of Smith-Lemli-Opitz syndrome (SLO) with p
roven defects in cholesterol biosynthesis are compared, and shown to b
e markedly disparate even between sibs, and demonstrate the dilemma fo
r the clinician. The advent of a biochemical test for SLO has been eno
rmously valuable in determining which patients are truly affected by t
he condition, but because of the wide phenotypic variation, a diagnosi
s on clinical features alone remains problematic.